Troutman Pepper advised BayState Eye Center on the deal. BayState Eye Center announced an equity investment with HG Vision for BayState Eye Center’s optometry practices in Plymouth,...
BayState Eye Center’s Equity Investment with HG Vision
WindRose Health Investors’ Acquisition of Ganse Apothecary
Troutman Pepper advised Ganse Apothecary on the deal. Ganse Apothecary, a Pennsylvania-based closed-door long-term care and specialty pharmacy, announced its acquisition by WindRose Health Investors, a...
Onkos Surgical’s Acquisition of JTS Extendible Prosthesis
Troutman Pepper Hamilton Sanders advised Onkos Surgical, Inc. on the deal. Onkos Surgical, Inc., a leading innovator of solutions for musculoskeletal oncology and complex orthopedic conditions,...
BW Digital’s Acquisition of Hawaiki
Troutman Pepper Hamilton Sanders advised BW Digital Pte. Ltd on the deal. BW Digital announced the acquisition of 100% of Hawaiki Submarine Cable Limited Partnership and International...
Civic Eagle’s $10 Million Funding Round
Troutman Pepper advised Civic Eagle on the deal. Civic Eagle, a technology company providing legislative data and intelligence software solutions, announced its $10 million funding round. The...
Hikma Pharmaceuticals’ $375 Million Acquisition of Custopharm
Troutman Pepper advised Hikma Pharmaceuticals PLC on the deal. Hikma Pharmaceuticals PLC, a multinational pharmaceutical company, has acquired Custopharm Inc. from Water Street Healthcare Partners, following...
John Edelman’s Acquisition of Heller
Troutman Pepper Hamilton Sanders advised Heller on the deal. Heller, a leading industrial furniture manufacturer known for offering good design at accessible prices, announced its sale to John...
Southfield Capital’s Partnership with Franchise FastLane
Troutman Pepper advised Southfield Capital, and Koley Jessen advised Franchise FastLane. Southfield Capital, a premier lower middle market private equity firm, has announced a partnership with...
Apnimed’s Series C Financing
Troutman Pepper advised Apnimed on the deal. Apnimed, a clinical-stage pharmaceutical company focused on developing oral pharmacologic treatments to address obstructive sleep apnea (OSA) and related...
Botanix Pharmaceuticals Limited’s Acquisition of Sofpironium Bromide
Troutman Pepper advised Botanix Pharmaceuticals Limited on the deal. Botanix Pharmaceuticals Limited (ASX: BOT), a clinical dermatology company, has announced the acquisition of Sofpironium Bromide gel,...
Trevena’s Royalty-Based Financing Agreement with R-Bridge Healthcare Fund
Troutman Pepper advised Trevena on the deal. Trevena, a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system...
Payroc WorldAccess, LLC’s Acquisition of Worldnet
McCann FitzGerald LLP has advised Worldnet on the deal while Troutman Pepper represented Payroc WorldAccess, LLC. Worldnet, a leading integrated payment gateway and platform provider for...